View Older Stories

May 11, 2026 05:52AM Crinetics (CRNX) PT Lowered to $84 at Oppenheimer

May 8, 2026 04:51AM Crinetics (CRNX) PT Lowered to $95 at Citizens After Q1 Results

May 7, 2026 05:28PM Crinetics Pharmaceuticals (CRNX) Tops Q1 EPS by 5c

Apr 28, 2026 04:06AM Crinetics (CRNX) PT Raised to $97 at Citizens on Palsonify's EU Approval

Apr 27, 2026 05:15PM Crinetics gets European approval for acromegaly drug PALSONIFY

Mar 26, 2026 04:07PM Crinetics submits marketing application for Palsonify in Brazil

Mar 2, 2026 05:12AM Crinetics (CRNX) PT Lowered to $96 at Citizens on Multiple Pivotal Readouts Ahead

Feb 26, 2026 04:49PM Crinetics Pharmaceuticals (CRNX) Tops Q4 EPS by 5c

Jan 12, 2026 05:06AM Goldman Sachs Upgrades Crinetics (CRNX) to Buy

Jan 8, 2026 04:26AM Crinetics (CRNX) PT Lowered to $105 at Citizens: Palsonify Experience Positive

Jan 6, 2026 06:58AM Oppenheimer Reiterates Outperform Rating on Crinetics (CRNX)

Jan 6, 2026 06:43AM H.C. Wainwright Reiterates Buy Rating on Crinetics (CRNX)

Jan 5, 2026 01:48PM Crinetics (CRNX) PT Raised to $97 at Jones Trading

Jan 5, 2026 01:44PM Crinetics (CRNX) PT Raised to $80 at Morgan Stanley

Jan 5, 2026 01:39PM Baird on Crinetics (CRNX): 'Palsonify off to a great start, expect upwards revision to estimates'

Jan 5, 2026 10:22AM Crinetics (CRNX) PT Raised to $90 at Evercore ISI

Jan 5, 2026 10:04AM Stifel Reiterates Buy Rating on Crinetics (CRNX)

Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note

Dec 8, 2025 07:32AM Piper Sandler on Biotechnology: 'What Commercial Names to Own in 2026?'

Nov 6, 2025 04:30PM Crinetics Pharmaceuticals (CRNX) Misses Q3 EPS by 13c

Oct 8, 2025 08:54AM Piper Sandler on Crinetics (CRNX): 'We Are Buyers and Continue to Be Bullish'

Sep 30, 2025 05:31AM Crinetics (CRNX) PT Raised to $87 at Oppenheimer

Sep 29, 2025 03:18PM Crinetics (CRNX) PT Raised to $75 at Stifel

Sep 29, 2025 07:59AM Piper Sandler: 'We Remain Bullish on Crinetics (CRNX)'

Sep 29, 2025 07:20AM Crinetics (CRNX) PT Raised to $88 at Leerink Partners

Sep 26, 2025 07:39AM Crinetics (CRNX) PT Raised to $77 at Morgan Stanley

Sep 26, 2025 07:06AM Stifel Reiterates Buy Rating on Crinetics (CRNX)

Sep 26, 2025 07:02AM Crinetics (CRNX) PT Raised to $85 at Jones Trading

Sep 26, 2025 06:47AM H.C. Wainwright Reiterates Buy Rating on Crinetics (CRNX)

Sep 26, 2025 06:43AM Cantor Fitzgerald Reiterates Overweight Rating on Crinetics (CRNX)

Sep 26, 2025 06:02AM Oppenheimer Reiterates Outperform Rating on Crinetics (CRNX)

Sep 26, 2025 04:56AM Crinetics (CRNX) PT Raised to $62 at Baird

Sep 26, 2025 04:20AM Crinetics (CRNX) PT Raised to $143 at Citizens JMP

Sep 23, 2025 06:50AM Cantor Fitzgerald Reiterates Overweight Rating on Crinetics (CRNX)

Aug 21, 2025 08:45AM Crinetics receives FDA orphan drug designation for CAH treatment

Aug 11, 2025 04:05AM Crinetics (CRNX) PT Lowered to $86 at Citizens JMP

Aug 8, 2025 03:43PM Crinetics (CRNX) PT Lowered to $65 at Jones Trading

Aug 8, 2025 07:49AM Crinetics (CRNX) PT Lowered to $58 at Stifel, 'Building Commercial Launch Readiness Ahead of 9/25 PDUFA'

Aug 7, 2025 04:42PM Crinetics Pharmaceuticals (CRNX) Misses Q2 EPS by 13c

Jul 21, 2025 09:11AM Piper Sandler: 'We Remain Bullish on Crinetics (CRNX)'

Jul 21, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Crinetics (CRNX)

Jul 17, 2025 12:44PM Jones Trading Reiterates Buy Rating on Crinetics (CRNX)

Jul 15, 2025 04:37AM Citizens JMP Reiterates Market Outperform Rating on Crinetics (CRNX)

Jul 10, 2025 05:21AM Goldman Sachs Starts Crinetics (CRNX) at Neutral

Jul 2, 2025 04:08AM Citizens JMP Reiterates Market Outperform Rating on Crinetics (CRNX)

Jun 27, 2025 06:51AM H.C. Wainwright Reiterates Buy Rating on Crinetics (CRNX)

May 30, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Crinetics (CRNX)

May 8, 2025 06:47PM Crinetics Pharmaceuticals (CRNX) Misses Q1 EPS by 11c

Apr 11, 2025 09:44AM Piper Sandler: 'What Biotech Names to Own in Market Volatility'

Apr 2, 2025 09:07AM Stifel shares update on CAH stocks following conversation with physicians

View Older Stories